Drug intelligence / Profile preview

2,4-diamino-6-[N-(3',5'-dimethoxybenzyl)-N-methylamino]pyrido[2,3-d]pyrimidine

Development stage
Unknown
Modality
Small Molecules
01

Overview

This compound is a synthetic small molecule belonging to the pyridopyrimidine class. It has the molecular formula C17H20N6O2 and a molecular weight of approximately 340.38 g/mol. The structure features a pyrido[2,3-d]pyrimidine core substituted with two amino groups at positions 2 and 4 and an N-methyl-N-(3',5'-dimethoxybenzyl)amino group at position 6. It is cataloged as an experimental compound in chemical databases but does not have any approved pharmaceutical use or well-characterized mechanism of action reported in public sources. Its primary relevance appears to be as a research tool or chemical probe rather than as a marketed drug or clinical candidate[1][2][5].

Other names
N6-[(3,5-dimethoxyphenyl)methyl]-N6-methylpyrido[2,3-d]pyrimidine-2,4,6-triamine2,4-Diamino-6-(N-(3',5'-Dimethoxybenzyl)-N-Methylamino)Pyrido(2,3-D)Pyrimidine
02

Targets

TgDHFR-TS (Toxoplasma gondii dihydrofolate reductase-thymidylate synthase)DHFR (Dihydrofolate reductase)

Beyond the preview

Go deeper on 2,4-diamino-6-[N-(3',5'-dimethoxybenzyl)-N-methylamino]pyrido[2,3-d]pyrimidine.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on 2,4-diamino-6-[N-(3',5'-dimethoxybenzyl)-N-methylamino]pyrido[2,3-d]pyrimidine.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call